ZYVERSA THERAPEUTICS, INC. Derivative Liability, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Derivative Liability, Current of $560.60 thousand as of 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-03-31
- 2021-12-31: Derivative Liability, Current $560.60K; Derivative Liability, Current as first filed $76.59K.
- 2020-12-31: Derivative Liability, Current $788.70K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2021-12-31 | $560.60K 10-K · filed 2023-03-31 | $76.59K 10-K · filed 2022-04-15 |
| 2020-12-31 | $788.70K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |